MERO, the Czech pipeline operator: The oil transportation to the Czech Republic through the "Friendship" pipeline continues to run as planned.India's new central bank governor: policy stability is very important and will try to maintain policy continuity.The probability of the Bank of Japan raising interest rates this month doesn't seem to increase the strength of the US/Japan again. Justin Low, an analyst at Forexlive, a financial website, said that the possibility of the Bank of Japan raising interest rates this month was very low from the beginning, and earlier today, the ratio was about 30%. There has just been a sudden report that some policy makers of the Bank of Japan may support raising interest rates in December, but they also think it is unnecessary to rush because they think the cost of waiting for raising interest rates is "very small". After this news, the possibility of the Bank of Japan raising interest rates further dropped to about 23%. This, in turn, led to buying against the yen, while the yen fell. In the initial reaction, USD/JPY once fell to a low of 150.99, but then rose to around 152.30.
Macy's fell 8.2% before the market, and the company lowered its profit outlook after discovering accounting errors.At the opening of the night session, the main contract of No.20 glue rose by nearly 2%, and the main contracts of low sulfur fuel oil (LU) and coking coal rose by over 1%. In terms of decline, the main contract of alumina fell by more than 1%, and the main contract of palm oil and soybean meal fell by nearly 1%.Pinduoduo stocks fell more than 3% before trading.
Good shop: shareholder Dayong Co., Ltd. reduced its holdings by 3% in this reduction plan, which has reached the upper limit of the reduction plan. The good shop announced that during the period from December 2, 2024 to December 10, 2024, shareholder Dayong Co., Ltd. reduced its holdings by 4,560,400 shares, accounting for 1.14% of the company's total share capital. As of December 11, 2024, shareholder Dayong Co., Ltd. has reduced its shareholding by 3% in this reduction plan, which has reached the upper limit of the reduction plan, and the implementation of this reduction plan has been completed.Huayuan Real Estate: It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company. Huayuan Real Estate announced the change, and the company is planning major asset sales and related transactions. It is planned to transfer the assets and liabilities related to real estate development business to Huayuan Group, the controlling shareholder of the company, that is, the company plans to transfer 100% equity of Huayuan Real Estate. As of the evaluation benchmark date (April 30, 2024), the company's receivables from Huayuan Real Estate and its subsidiaries are as follows.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14